Effects of lovastatin on natural killer cell function and other immunological parameters in man
- 1 November 1993
- journal article
- research article
- Published by Springer Nature in Journal of Clinical Immunology
- Vol. 13 (6), 439-444
- https://doi.org/10.1007/bf00920019
Abstract
Suppression of cholesterol synthesis by 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors, such as lovastatin, has been shown to inhibit mitogen stimulated proliferation of natural killer (NK) cells and other lymphocytesin vitro. This effect is only partially overcome by provision of exogenous free or lipoprotein cholesterol but is reversed by mevalonate, suggesting that proliferating lymphocytes have a specific requirement for a nonsterol isoprenoid product of mevalonate. The effect of lovastatin (20 mg bid) on a range of immune function parameters was determined in a randomized, placebo-controlled, double-blindex vivo study in 52 patients with primary hypercholesterolemia. No significant differences (Pin vitro data, no statistically or clinically significant changes were observed in any parameter of lymphocyte function in patients treated with lovastatin.Keywords
This publication has 12 references indexed in Scilit:
- Might treatment of hypercholesterolaemia increase non-cardiac mortality?The Lancet, 1991
- Reversal of lovastatin‐mediated inhibition of natural killer cell cytotoxicity by interleukin 2Journal of Cellular Physiology, 1990
- Cellular cholesterol metabolism in mitogen-stimulated lymphocytes — Requirement for de novo synthesisBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1990
- Role of mevalonic acid in the regulation of natural killer cell cytotoxicityJournal of Cellular Physiology, 1989
- Suppression of lymphoid cell function in vitro by inhibition of 3-hydroxy-3-methylglutaryl coenzyme a reductase by lovastatinInternational Journal of Immunopharmacology, 1989
- Biology of Natural Killer CellsAdvances in Immunology, 1989
- Detection of Familial Hypercholesterolemia by Assaying Functional Low-Density-Lipoprotein Receptors on LymphocytesNew England Journal of Medicine, 1986
- The standardization of NK cell assays for use in studies of biological response modifiersJournal of Immunological Methods, 1984
- Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.The Journal of Experimental Medicine, 1982
- Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. IX. The quantitation of natural killer cell activityJournal of Clinical Immunology, 1981